In a new study, researchers discovered that the retina of schizophrenia patients differs from the retina of healthy participants. These changes could help psychiatrists to recognize who will have a particularly severe course of illness.
We are still waiting biomarkers for early diagnosis of schizophrenia spectrum disorder that are promised since eons. Nothing changes in the mud of boots on the ground of clinical psychiatry as if research was an hermetically self-contained area from which nothing escapes.
@SkinnyMe I think that biomarkers like retinas screening for early diagnosis (better prognosis) are promised to be available for everyone since quite a long time ago. But nothing new has arrived in the daily practice of psychiatry. Same thing for breakthrough in medication. We are still waiting for revolutionary medicine. Development is very slow in this field as if research could not lead to applications.